Immune System News and Research

RSS

Researchers investigate why immune system is blunted after spinal cord injury

Mobility is a challenge for spinal cord injured patients. Infection is another. Adam Thrasher, assistant professor of health and human performance, says infection is the leading cause of death for people living with spinal cord injuries for two years or more.

4 Mar 2011

Dentists need to take a closer look at potential hazards of exposing patients to zinc

Dentists need to take a closer look at potential hazards of exposing patients to zinc, a common ingredient of many dental products, according to a report by Amar Patel, DDS, resident and colleagues at the University of Maryland Dental School in the March/April 2011 issue of the journal General Dentistry.

4 Mar 2011

BioSante vaccine increases median survival of resected pancreatic cancer patients

BioSante Pharmaceuticals, Inc. today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent.

4 Mar 2011

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

Immune Network Ltd. advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and Immunitor for further clinical research of a tableted form of Ekomed's well-known immunomodulator herbal product Immunoxel/Dzherelo.

4 Mar 2011

Executioner enzyme may short circuit second form of cell death

An enzyme viewed as an executioner, because it can push cells to commit suicide, may actually short circuit a second form of cell death, researchers at Emory University School of Medicine have discovered.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

First artificial bronchus graft in a lung cancer patient successful

In a medical breakthrough French surgeons have grafted an artificial airway to save a lung afflicted by bronchial cancer in a 78-year-old man. The bronchi are the main tubes or airways used for taking air from the trachea to the two sides of the lung.

3 Mar 2011

Stem cell research updates

Two studies have been published this Wednesday in the journal Nature that show that work remains before so-called induced pluripotent stem (iPS) cells are ready for use in laboratory studies or clinical therapies. These iPS cells are body cells that are programmed to unwind back into an embryonic state. Like embryonic stem cells, they have potential to develop into any other type of cell in the body. However researchers are showing that these cells do not reprogram perfectly.

3 Mar 2011

'Implementation science' approach to play a critical role in next phase of PEPFAR program

An "implementation science" approach will play a critical role in the next phase of The U.S. President's Emergency Plan for AIDS Relief, according to an editorial in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Mar 2011

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.

3 Mar 2011

New research provides insight into link between sunlight, vitamin D3, MS risk and severity

New research into the neurodegenerative disease, Multiple Sclerosis offers new insight into the link between sunlight, vitamin D3, and MS risk and severity.

3 Mar 2011

Study reveals expansion of NK cells after acute infection

The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass.

3 Mar 2011

Groundbreaking discovery in lymphoma research

BC Cancer Agency scientists have discovered that a single gene, CIITA, is implicated in almost 40 per cent of primary mediastinal B-cell lymphomas and 15 per cent of all Hodgkin lymphoma cases.

3 Mar 2011

Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine

Vical Incorporated announced today the receipt of Scientific Advice from the European Medicines Agency (EMA) recommending practical efficacy endpoints for a Phase 3 trial of the company's TransVax™ therapeutic cytomegalovirus (CMV) vaccine.

3 Mar 2011

New breakthrough in immunological research

Immunological research at the University of Haifa, Israel, has made a new breakthrough, revealing a critical component in the "decision-making" process of white blood cells that play a role in the healing process from bacterial inflammation.

3 Mar 2011

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.

3 Mar 2011

FADD protein discovery can lead to better cancer and autoimmune disease drugs

Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs.

3 Mar 2011

Scientists provide new insight into mechanisms controlling programmed cell death pathways

Work led by St. Jude Children's Research Hospital investigators provides fresh insight into mechanisms controlling programmed cell death pathways and offers new targets in the fight against cancer and virus-infected cells

3 Mar 2011

New microfluidic device may help clinicians to improve cancer therapy

Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia and neuroblastoma.

3 Mar 2011

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

The Translational Health Sciences and Technology Institute, an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India.

2 Mar 2011

Immune System News and Research

Researchers investigate why immune system is blunted after spinal cord injury

Dentists need to take a closer look at potential hazards of exposing patients to zinc

BioSante vaccine increases median survival of resected pancreatic cancer patients

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

Executioner enzyme may short circuit second form of cell death

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

First artificial bronchus graft in a lung cancer patient successful

Stem cell research updates

'Implementation science' approach to play a critical role in next phase of PEPFAR program

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

New research provides insight into link between sunlight, vitamin D3, MS risk and severity

Study reveals expansion of NK cells after acute infection

Groundbreaking discovery in lymphoma research

Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine

New breakthrough in immunological research

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

FADD protein discovery can lead to better cancer and autoimmune disease drugs

Scientists provide new insight into mechanisms controlling programmed cell death pathways

New microfluidic device may help clinicians to improve cancer therapy

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

Immunology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News